PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 126 filers reported holding PLIANT THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,089,766 | -26.9% | 985,569 | -23.6% | 0.01% | -8.3% |
| Q2 2023 | $23,386,614 | -22.0% | 1,290,652 | +14.6% | 0.01% | -29.4% |
| Q1 2023 | $29,965,671 | +391.7% | 1,126,529 | +257.3% | 0.02% | +325.0% |
| Q4 2022 | $6,094,904 | -5.5% | 315,308 | +2.2% | 0.00% | 0.0% |
| Q3 2022 | $6,447,000 | +160.8% | 308,618 | 0.0% | 0.00% | +300.0% |
| Q2 2022 | $2,472,000 | +1515.7% | 308,618 | +1316.5% | 0.00% | – |
| Q1 2022 | $153,000 | -25.7% | 21,787 | +42.8% | 0.00% | – |
| Q4 2021 | $206,000 | -15.9% | 15,261 | +5.4% | 0.00% | – |
| Q3 2021 | $245,000 | -43.7% | 14,481 | -3.0% | 0.00% | – |
| Q2 2021 | $435,000 | -29.8% | 14,926 | -5.4% | 0.00% | – |
| Q1 2021 | $620,000 | +250.3% | 15,775 | +103.0% | 0.00% | – |
| Q4 2020 | $177,000 | +40.5% | 7,771 | +39.6% | 0.00% | – |
| Q3 2020 | $126,000 | – | 5,566 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
| CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
| TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
| GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
| First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
| Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
| Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
| Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
| Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |